BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 29471245)

  • 1. Intraperitoneal administration of mesenchymal stem cells ameliorates acute dextran sulfate sodium-induced colitis by suppressing dendritic cells.
    Nikolic A; Simovic Markovic B; Gazdic M; Randall Harrell C; Fellabaum C; Jovicic N; Djonov V; Arsenijevic N; L Lukic M; Stojkovic M; Volarevic V
    Biomed Pharmacother; 2018 Apr; 100():426-432. PubMed ID: 29471245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory Dendritic Cells Induced by Mesenchymal Stem Cells Ameliorate Dextran Sodium Sulfate-Induced Chronic Colitis in Mice.
    Jo H; Eom YW; Kim HS; Park HJ; Kim HM; Cho MY
    Gut Liver; 2018 Nov; 12(6):664-673. PubMed ID: 29938461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous vs intraperitoneal mesenchymal stem cells administration: what is the best route for treating experimental colitis?
    Gonçalves Fda C; Schneider N; Pinto FO; Meyer FS; Visioli F; Pfaffenseller B; Lopez PL; Passos EP; Cirne-Lima EO; Meurer L; Paz AH
    World J Gastroenterol; 2014 Dec; 20(48):18228-39. PubMed ID: 25561790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous administration of mesenchymal stem cells ameliorates dextran sulfate sodium-induced colitis via anti-inflammatory action in damaged tissue in rats.
    Tanaka F; Tominaga K; Ochi M; Tanigawa T; Watanabe T; Fujiwara Y; Ohta K; Oshitani N; Higuchi K; Arakawa T
    Life Sci; 2008 Dec; 83(23-24):771-9. PubMed ID: 18950645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Therapeutic Efficacy of Tonsil-derived Mesenchymal Stem Cells in Dextran Sulfate Sodium-induced Acute Murine Colitis Model.
    Song EM; Jung SA; Lee KE; Jang JY; Lee KH; Tae CH; Moon CM; Joo YH; Kim SE; Jung HK; Shim KN
    Korean J Gastroenterol; 2017 Feb; 69(2):119-128. PubMed ID: 28239080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-3 Plays an Important Pro-inflammatory Role in the Induction Phase of Acute Colitis by Promoting Activation of NLRP3 Inflammasome and Production of IL-1β in Macrophages.
    Simovic Markovic B; Nikolic A; Gazdic M; Bojic S; Vucicevic L; Kosic M; Mitrovic S; Milosavljevic M; Besra G; Trajkovic V; Arsenijevic N; Lukic ML; Volarevic V
    J Crohns Colitis; 2016 May; 10(5):593-606. PubMed ID: 26786981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2.
    Kim HS; Shin TH; Lee BC; Yu KR; Seo Y; Lee S; Seo MS; Hong IS; Choi SW; Seo KW; Núñez G; Park JH; Kang KS
    Gastroenterology; 2013 Dec; 145(6):1392-403.e1-8. PubMed ID: 23973922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The therapeutic efficacy of mesenchymal stromal cells on experimental colitis was improved by the IFN-γ and poly(I:C) priming through promoting the expression of indoleamine 2,3-dioxygenase.
    Lim JY; Kim BS; Ryu DB; Kim TW; Park G; Min CK
    Stem Cell Res Ther; 2021 Jan; 12(1):37. PubMed ID: 33413597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative impact of bone-marrow-derived mesenchymal stem cells on dextran sulfate sodium-induced colitis.
    Nam YS; Kim N; Im KI; Lim JY; Lee ES; Cho SG
    World J Gastroenterol; 2015 Feb; 21(7):2030-9. PubMed ID: 25717235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of unlicensed bone marrow-derived platelet lysate-expanded mesenchymal stromal cells in colitis: a pre-clinical study.
    Salmenkari H; Laitinen A; Forsgård RA; Holappa M; Lindén J; Pasanen L; Korhonen M; Korpela R; Nystedt J
    Cytotherapy; 2019 Feb; 21(2):175-188. PubMed ID: 30611671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intercellular adhesion molecule-1 enhances the therapeutic effects of MSCs in a dextran sulfate sodium-induced colitis models by promoting MSCs homing to murine colons and spleens.
    Li X; Wang Q; Ding L; Wang YX; Zhao ZD; Mao N; Wu CT; Wang H; Zhu H; Ning SB
    Stem Cell Res Ther; 2019 Aug; 10(1):267. PubMed ID: 31443680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of tonsil-derived mesenchymal stem cells in dextran sulfate sodium-induced experimental murine colitis.
    Yu Y; Song EM; Lee KE; Joo YH; Kim SE; Moon CM; Kim HY; Jung SA; Jo I
    PLoS One; 2017; 12(8):e0183141. PubMed ID: 28854223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Berberine ameliorates chronic relapsing dextran sulfate sodium-induced colitis in C57BL/6 mice by suppressing Th17 responses.
    Li YH; Xiao HT; Hu DD; Fatima S; Lin CY; Mu HX; Lee NP; Bian ZX
    Pharmacol Res; 2016 Aug; 110():227-239. PubMed ID: 26969793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraluminal Injection of Mesenchymal Stromal Cells in Spheroids Attenuates Experimental Colitis.
    Molendijk I; Barnhoorn MC; de Jonge-Muller ES; Mieremet-Ooms MA; van der Reijden JJ; van der Helm D; Hommes DW; van der Meulen-de Jong AE; Verspaget HW
    J Crohns Colitis; 2016 Aug; 10(8):953-64. PubMed ID: 26896084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of TGF-β and IL-10 production in dendritic cells using astilbin to inhibit dextran sulfate sodium-induced colitis.
    Ding Y; Liang Y; Deng B; Qiao A; Wu K; Xiao W; Gong W
    Biochem Biophys Res Commun; 2014 Apr; 446(2):529-34. PubMed ID: 24613838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic infusion of bone marrow-derived mesenchymal stem cells for treatment of experimental colitis in mice.
    He XW; He XS; Lian L; Wu XJ; Lan P
    Dig Dis Sci; 2012 Dec; 57(12):3136-44. PubMed ID: 22752635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early injection of human adipose tissue-derived mesenchymal stem cell after inflammation ameliorates dextran sulfate sodium-induced colitis in mice through the induction of M2 macrophages and regulatory T cells.
    Kawata Y; Tsuchiya A; Seino S; Watanabe Y; Kojima Y; Ikarashi S; Tominaga K; Yokoyama J; Yamagiwa S; Terai S
    Cell Tissue Res; 2019 May; 376(2):257-271. PubMed ID: 30635774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine.
    Sala E; Genua M; Petti L; Anselmo A; Arena V; Cibella J; Zanotti L; D'Alessio S; Scaldaferri F; Luca G; Arato I; Calafiore R; Sgambato A; Rutella S; Locati M; Danese S; Vetrano S
    Gastroenterology; 2015 Jul; 149(1):163-176.e20. PubMed ID: 25790743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Effects of Bone Marrow-Derived Mesenchymal Stem Cells in Dextran Sulfate Sodium-Induced Murine Chronic Colitis.
    Lee HJ; Oh SH; Jang HW; Kwon JH; Lee KJ; Kim CH; Park SJ; Hong SP; Cheon JH; Kim TI; Kim WH
    Gut Liver; 2016 May; 10(3):412-9. PubMed ID: 27114436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic Administration of Mesenchymal Stromal Cells Reduces Inflammation in Experimental Colitis.
    Barnhoorn M; de Jonge-Muller E; Molendijk I; van Gulijk M; Lebbink O; Janson S; Schoonderwoerd M; van der Helm D; van der Meulen-de Jong A; Hawinkels L; Verspaget H
    Inflamm Bowel Dis; 2018 Jul; 24(8):1755-1767. PubMed ID: 29796655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.